IZB start-up AMSilk GmbH Building a sustainable future this is what drives us. We are passionate about making smart biotech materials part of everyday life. We believe nature offers better alternatives to existing materials … more ➔
Automated workflowThe SARS-CoV-2 virus global outbreak generated a need for fast and reliable large-scale testing. One of the main bottlenecks of the PCR test is the laborious and time-consuming molecular method for viral … more ➔
How to Safely Handle Your Antibody Drug Co...ADCs have huge potential in treating challenging diseases such as cancer. However, it is essential that all necessary equipment, steps, and precautions are in place to en¬sure their safe handling. more ➔
Sino Biological and Ainnocence Partner to...Beijing, China March 22, 2022 Sino Biological, Inc. (Sino Biological or the Company), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which … more ➔
Austria magnet for biotechnologyThe life sciences location of Austria has gained considerable momentum since the founding of the very first Austrian biotech company Intercell at the turn of the millennium. Today the whos who of … more ➔
Life-sciences hub Saxony: a driver of inno...Saxony has established itself as a dynamic life-sciences hub and provides an attractive environment for investors and start-ups The SaxoCell network and CMI major research centre are furthering … more ➔
Sino Biological Establishes New Location i...Houston, TX, December 31, 2021 Sino Biological, Inc. (Sino Biological or the Company), a biotechnology company listed on ChiNext (SZSE: 301047), provides biological research reagents and related … more ➔
Sino Biological Deposits Recombinant Omicr...Houston, TX, December 31, 2021Sino Biological, Inc. (SZSE: 301047) has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products … more ➔
Accelerating biologics developmentAbstract: This report provides a roadmap for assessing and selecting the right partner to get promising biological therapies to patients quickly. Criteria includes: more ➔
Accelerating biologics developmentAbstract: This report provides a roadmap for assessing and selecting the right partner to get promising biological therapies to patients quickly. Criteria includes: more ➔
